Sax Wealth Advisors LLC purchased a new position in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,236 shares of the technology company’s stock, valued at approximately $583,000.
Other large investors have also recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Plexus in the 2nd quarter worth about $32,000. Kilter Group LLC bought a new stake in Plexus in the second quarter worth about $40,000. Integrated Wealth Concepts LLC purchased a new position in shares of Plexus during the second quarter valued at approximately $51,000. Persistent Asset Partners Ltd purchased a new position in shares of Plexus during the second quarter valued at approximately $71,000. Finally, Caitlin John LLC purchased a new position in shares of Plexus during the second quarter valued at approximately $74,000. 94.45% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Plexus
In related news, Director Karen Rapp sold 500 shares of the business’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the completion of the sale, the director owned 7,535 shares in the company, valued at approximately $1,814,955.45. The trade was a 6.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael V. Schrock sold 4,000 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total value of $1,100,000.00. Following the completion of the transaction, the director directly owned 40,329 shares in the company, valued at approximately $11,090,475. This trade represents a 9.02% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 7,500 shares of company stock worth $1,960,520. Company insiders own 1.78% of the company’s stock.
Plexus Trading Down 2.9%
Shares of PLXS opened at $238.71 on Friday. Plexus Corp. has a 1-year low of $132.03 and a 1-year high of $307.06. The company has a 50-day moving average of $254.29 and a 200 day moving average of $257.61. The firm has a market capitalization of $6.39 billion, a price-to-earnings ratio of 36.24 and a beta of 0.88. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72.
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.19. The company had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm’s quarterly revenue was up 28.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, research analysts expect that Plexus Corp. will post 7.13 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on PLXS. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research note on Sunday, October 4th. Weiss Ratings raised Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Needham & Company LLC restated a “buy” rating and set a $310.00 price objective on shares of Plexus in a report on Friday, August 14th. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Finally, Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective on the stock in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $276.86.
View Our Latest Report on Plexus
Plexus Profile
Plexus Corp. (NASDAQ: PLXS) is an electronics manufacturing services and product development company headquartered in Neenah, Wisconsin. The company helps customers design, engineer, manufacture and service complex electronic products, offering capabilities that span product development, printed circuit board assembly, systems integration, testing, supply-chain management and aftermarket support.
Plexus serves customers in markets including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.
Featured Stories
- Five stocks we like better than Plexus
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
